Brian McGuinness joins the Alacrita team

Alacrita welcomes Brian McGuinness to the team.

Brian has over 17 years experience in research and business development in biopharmaceuticals, particularly with Cambridge Antibody Technology (CAT) and Astra Zeneca plc.

During the past three years as a consultant to the industry, Brian has undertaken strategic portfolio reviews, conducted due diligence on behalf of venture capital investors and has contributed to the preparation of business plans for Heptares Therapeutics and Crescendo Biologics.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Stay in touch